Skip to main
  1. Stocks
  2. Monte Rosa Therapeutics
  3. Market Cap
GLUE

GLUE Market Capitalization Overview

Market Cap: $927.36M as of Oct 29, 2026

$927.36M
$74.23M (7.41%)past month
As of Oct 29, 2026, GLUE has a market capitalization of $927.36M. Over the past 30 days, its market cap has decreased by -21.31%, while in the last 12 months, it has decreased by -9.18%.

Market capitalization represents the total value of Monte Rosa Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

GLUE Market Cap Formula = Stock Price * Shares Outstanding

The market cap of GLUE helps investors assess the company's size and compare it with competitors for better investment decisions.

GLUE Market Cap & Key Trends

See Monte Rosa Therapeutics’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.

Start investing in GLUE

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

GLUE Market Cap History

DateMarket CapChange
Oct 1, 2026$960.63M-21.31%
Sep 1, 2026$1.23B-6.04%
Aug 3, 2026$1.30B-35.97%
Jul 1, 2026$2.03B+22.11%
Jun 1, 2026$1.67B+10.46%
May 1, 2026$1.51B+9.49%
Apr 1, 2026$1.38B-2.60%
Mar 2, 2026$1.42B-11.40%
Feb 2, 2026$1.60B+59.68%
Jan 2, 2026$996.96M-2.98%

GLUE End of Year Market Cap History

DateMarket CapChange
2026$927.36M-9.18%
2025$1.03B+139.47%
2024$426.38M+50.68%
2023$282.96M-23.18%
2022$368.32M-61.22%
2021$949.66M—

FAQs About Monte Rosa Therapeutics (GLUE) Market Cap

As of Oct 29, 2026, the market capitalization of GLUE is $927.36M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Monte Rosa Therapeutics’s market capitalization has decreased by -7.41%, changing from $1.01B to $927.36M as of Oct 29, 2026.

In the last 3 months, Monte Rosa Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2025, Monte Rosa Therapeutics’s market capitalization increased from $426.38M in January to $1.03B in December, reflecting a 139.47% change.

In the past five years, GLUE has had a compound annual growth rate (CAGR) of 1.46% in market capitalization. This means its market cap has grown at an average rate of 1.46% per year.

Monte Rosa Therapeutics (GLUE)


GLUE Market Cap & Key Trends

See Monte Rosa Therapeutics’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.

Start investing in GLUE

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover GLUE stock data and trends